Postnova Opens New UK Office
Postnova Analytics has opened a dedicated office to enhance local support for its UK customers.
Postnova Analytics (Landsberg am Lech, Germany) has opened a dedicated office to enhance local support for its UK customers. The new company, Postnova Analytics UK Ltd., is based in Herefordshire, and is led by Paul Clarke, who has over 30 years experience in separation sciences.
The UK office has invested in a laboratory for demonstrations and applications development in the separation of particles, polymers, and proteins.
Thorsten Klein, Founder and CEO of Postnova Analytics, said, “Paul Clarke brings extensive experience of separation sciences, which means
that we can offer prospective and existing UK customers an even better service, from the first contact through to installation and aftersales support.”
Paul Clarke, Managing Director of Postnova Analytics UK, said, “I am delighted to join Postnova at an exciting stage in its international growth. I feel there is a real opportunity to explain and demonstrate the benefits of FFF to UK separation scientists and open up new applications using Postnova integrated FFF/SEC systems.”
For further information please visit www.postnova.com
New Study Examines PFAS in Breast Milk Using LC-MS/MS
November 5th 2024On the suggestion that per- and polyfluoroalkyl substances (PFAS) affect both lactation and the human metabolome, perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) were measured in the milk of 425 participants from the New Hampshire Birth Cohort Study using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
